Location History:
- L'Aquiula, IT (2017)
- L'Aquila, IT (2000 - 2023)
Company Filing History:
9 out of 49 
2 out of 22 
1 out of 105 Years Active: 2000-2025
Title: Laura Brandolini: Innovator in IL-8 Inhibitor Research
Introduction
Laura Brandolini is a prominent inventor based in L'Aquila, Italy. She has made significant contributions to the field of pharmaceutical research, particularly in the development of IL-8 inhibitors. With a total of 11 patents to her name, her work focuses on innovative treatments for various medical conditions.
Latest Patents
Among her latest patents, Laura has developed IL-8 inhibitors for use in the treatment of chemotherapy-induced peripheral neuropathy. This invention relates to IL-8 inhibitor compounds, specifically dual CXCR1/CXCR2 receptor inhibitors, which are useful in preventing and treating chemotherapy-induced neuropathy. Another notable patent addresses IL-8 inhibitors for the treatment of certain urological disorders, including interstitial cystitis/painful bladder syndrome and overactive bladder, particularly those induced by anticancer therapy. These patents also cover methods of treatment and combinations involving these IL-8 inhibitors.
Career Highlights
Laura has worked with notable companies such as Dompé Farmaceutici S.p.A. and Dompé S.p.A. Her experience in these organizations has allowed her to advance her research and contribute to the development of innovative pharmaceutical solutions.
Collaborations
Throughout her career, Laura has collaborated with esteemed colleagues, including Gianluca Bianchini and Andrea Aramini. These partnerships have played a crucial role in her research endeavors and patent developments.
Conclusion
Laura Brandolini stands out as a leading inventor in the field of IL-8 inhibitors, with a strong focus on improving treatments for patients undergoing chemotherapy and those suffering from urological disorders. Her contributions continue to impact the pharmaceutical industry positively.